Re: [Sbcl-help] cygwin compile error: missing genesis/Makefile.features

[<ter...@jp...>]

Well, you are not going to be able to run SBCL under Cygwin, regardless of 
what you do... believe me, I tried... hard! :)

Just get the windows binary and a windows emacs and slime and you are off 
to having fun with Nlisp ( i guess, never tried nlisp).

I built SBCL under Cygwin without clisp... but then learned the resulting 
binary would only run under Windows and no amount of pretending by me 
would change that :)
--
Terrence Brannon - SID W049945
614-213-2475 (office)
614-213-3426 (fax)
818-359-0893 (cell)





"Mirko Vukovic" <mir...@gm...> 
Sent by: sbc...@li...
01/23/2008 10:53 AM

To
sbc...@li...
cc

Subject
[Sbcl-help] cygwin compile error: missing genesis/Makefile.features






Hi,

I am using clisp 2.43 to try and compile sbcl (I would like to run Nlisp 
on it).

I am getting a couple of ignorable errors, but the build stops with
the error message
make: Entering directory `/tmp/sbcl-1.0.13/src/runtime'
GNUmakefile:31: genesis/Makefile.features: No such file or directory
make: *** No rule to make target `genesis/Makefile.features'.  Stop.
make: Leaving directory `/tmp/sbcl-1.0.13/src/runtime'

I saw some posts on the web about it but no answers.

Is that something easily fixed (I am not a lisp wizard), or should I
go to the experimental windows release?

Thank you,

Mirko

-------------------------------------------------------------------------
This SF.net email is sponsored by: Microsoft
Defy all challenges. Microsoft(R) Visual Studio 2008.
http://clk.atdmt.com/MRT/go/vse0120000070mrt/direct/01/
_______________________________________________
Sbcl-help mailing list
Sbc...@li...
https://lists.sourceforge.net/lists/listinfo/sbcl-help



-----------------------------------------
This communication is for informational purposes only. It is not
intended as an offer or solicitation for the purchase or sale of
any financial instrument or as an official confirmation of any
transaction. All market prices, data and other information are not
warranted as to completeness or accuracy and are subject to change
without notice. Any comments or statements made herein do not
necessarily reflect those of JPMorgan Chase & Co., its subsidiaries
and affiliates.

This transmission may contain information that is privileged,
confidential, legally privileged, and/or exempt from disclosure
under applicable law. If you are not the intended recipient, you
are hereby notified that any disclosure, copying, distribution, or
use of the information contained herein (including any reliance
thereon) is STRICTLY PROHIBITED. Although this transmission and any
attachments are believed to be free of any virus or other defect
that might affect any computer system into which it is received and
opened, it is the responsibility of the recipient to ensure that it
is virus free and no responsibility is accepted by JPMorgan Chase &
Co., its subsidiaries and affiliates, as applicable, for any loss
or damage arising in any way from its use. If you received this
transmission in error, please immediately contact the sender and
destroy the material in its entirety, whether in electronic or hard
copy format. Thank you.

Please refer to http://www.jpmorgan.com/pages/disclosures for
disclosures relating to UK legal entities.